Search results for "Complement"

showing 10 items of 2113 documents

The reconstitution of human C1, the first complement component Binding of C1r and C1s to C1q influences the C1q conformation

1981

Complement Activating EnzymesMacromolecular SubstancesProtein ConformationBiophysicsPlasma protein bindingBiochemistryProtein structureComplement C1Structural BiologyGeneticsHumansTrypsinMolecular BiologyComplement C1qComplement C1sEnzyme PrecursorsComplement C1sComplement C1rChemistryComponent (thermodynamics)Complement C1qComplement component 7Immunoglobulin Fc FragmentsCell BiologyHydrogen-Ion ConcentrationImmunoglobulin Fc FragmentsComplement (complexity)BiophysicsProtein BindingFEBS Letters
researchProduct

International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by …

2012

Background There are a limited number of publications on the management of gynecologic/obstetric events in female patients with hereditary angioedema caused by C1 inhibitor deficiency (HAE-C1-INH). Objective We sought to elaborate guidelines for optimizing the management of gynecologic/obstetric events in female patients with HAE-C1-INH. Methods A roundtable discussion took place at the 6th C1 Inhibitor Deficiency Workshop (May 2009, Budapest, Hungary). A review of related literature in English was performed. Results Contraception : Estrogens should be avoided. Barrier methods, intrauterine devices, and progestins can be used. Pregnancy : Attenuated androgens are contraindicated and should …

Complement C1 Inactivator ProteinsAbortionCardiovascularEcallantidechemistry.chemical_compoundDelivery Obstetric; Complement C1 Inactivator Proteins; Humans; Infant Newborn; Breast Neoplasms; Genetic Counseling; Pregnancy; Lactation; Genital Diseases Female; Infant; Contraception; Hereditary Angioedema Types I and II; Menstruation; Pregnancy Complications Cardiovascular; Chemoprevention; Prenatal Diagnosis; Menopause; FemalePregnancyIcatibantPrenatal DiagnosisImmunology and AllergyfertilityHereditary Angioedema Types I and IItreatmentObstetricsVaginal deliveryMenstruationContraceptioncontraceptionGenital DiseasesHereditary angioedemaFemalepregnancyMenopausedeliverymedicine.symptomComplement C1 Inhibitor ProteinDeliverymedicine.drugmedicine.medical_specialtyPregnancy Complications CardiovascularImmunologyBreast NeoplasmsGenetic CounselingIntrauterine deviceChemopreventionbreast cancermedicineHumansLactationGynecologyPregnancygenetic counselingAngioedemabusiness.industryangioedemaInfant NewbornInfantObstetricDelivery ObstetricNewbornmedicine.diseasehereditary angioedemaPregnancy ComplicationsSettore MED/16 - ReumatologiachemistryC1 inhibitor deficiencybusinessGenital Diseases FemaleJournal of Allergy and Clinical Immunology
researchProduct

Mode of interaction of different polyanions with the first (), the second (C2) and the fourth (C4) component of complement—II

1976

Abstract Dextran sulfate, polyvinyl sulfate, liquoid, heparin and Sp 54, ∗ (a pentosanpoly-sulfoester) prevented the uptake of C2 by EAC4b. In contrast to EAC 4 b 2 a , treatment of EAC4b2 with polyanions led to dissociation into EAC4b and C2. The inhibition of C2 uptake by polyanions could be reduced by increasing magnesium concentration to levels which are normally inhibitory, suggesting that Mg ++ ions are sequestered by these sulfated polyanions.

Complement component 2StereochemistryChemistryMagnesiumRehabilitationtechnology industry and agriculturechemistry.chemical_elementPhysical Therapy Sports Therapy and Rehabilitationmacromolecular substancesGeneral MedicineHeparinMedicinal chemistryDissociation (chemistry)SulfationDextran sulfatePolyvinyl sulfatemedicinemedicine.drugImmunochemistry
researchProduct

Combined complete C5 and partial C4 deficiency in humans: clinical consequences and complement-mediated functions in vitro.

1990

A family is described with two siblings who suffered at different times from a single episode of meningococcal meningitis by Neisseria meningitidis groups B and C, respectively. In the two subjects, hemolytically active fifth component of complement (C5) was not detectable and antigenic C5 was less than 0.05% and less than 0.7% of normal, respectively. Repletion of sera by purified human C5 (70 micrograms/ml) restored total complement hemolytic activities. The asymptomatic first degree family members had C5 levels compatible with a heterozygous state of C5 deficiency. C4 allotyping revealed an inherited partial deficiency (Q0) of C4A and C4B in the family with a combined C4AQ0 and C4BQ0 het…

Complement component 5AdultMaleAdolescentImmunologyC4AComplement C5Complement C4C5 DeficiencyBiologyPathology and Forensic MedicinePedigreeClassical complement pathwayImmune systemAntigenImmunologyAlternative complement pathwayImmunology and AllergyHumansFemaleImmunoglobulin AllotypesOpsoninComplement ActivationClinical immunology and immunopathology
researchProduct

Complement receptors on lymphocytes

1981

Complement component 5Cancer ResearchErythrocytesRosette FormationSheepComplement component 2CD46ChemistryComplement C3General MedicineComplement receptorImmune receptorBurkitt LymphomaComplement factor BCell LineReceptors ComplementClassical complement pathwayOncologyImmunologyAnimalsHumansLymphocytesCFHR5Journal of Cancer Research and Clinical Oncology
researchProduct

LE AREE INTERNE PER LO SVILUPPO DEL TERRITORIO E LA COMPLEMENTARITÀ DI PROGRAMMI E STRUMENTI FRA LE POLITICHE EUROPEE DI SVILUPPO RURALE E DI COESIONE

Le Aree Interne rappresentano un tema particolarmente importante per la programmazione e la spesa dei fondi comunitari nel periodo 2014-2020 perché costituiscono il più grande esempio di complementarità fra le Politiche europee di sviluppo rurale e di coesione. Per lo sviluppo di queste Aree è stata creata una Strategia Nazionale per le Aree Interne (SNAI) che mira alla valorizzazione ed al recupero di tutti quei territori (rurali, montuosi, svantaggiati) dal carattere marginale rispetto alla disponibilità e all’offerta di servizi essenziali. La peculiarità di tale Strategia è quella di promuovere lo sviluppo di aree che sono uniformemente distribuite in tutto il comprensorio nazionale a di…

Complementarity Rural Development Policy Cohesion Policy Internal Areas National Strategy for Internal Areas European funds the Common Strategic Framework ERDF ESF EAFRD local development LEADER Integrated Territorial Investment (ITI) Community Led Local Development (CLLD) convergence European planning 2014-2020Complementarità Politica di sviluppo rurale Politica di coesione Aree Interne Strategia Nazionale per le Aree Interne fondi comunitari Quadro Strategico Comune FESR FSE FEASR sviluppo locale LEADER Investimenti Territoriali Integrati (ITI) Community Led Local Development (CLLD) convergenza programmazione europea 2014-2020
researchProduct

CD83+ autologous human dendritic cells transfected with tumorpeptide CDNA: A potential tool for gene-immunotherapy?

1998

Complementary DNAmedicine.medical_treatmentmedicineDermatologyTransfectionImmunotherapyBiologyMolecular BiologyBiochemistryGeneMolecular biologyJournal of Dermatological Science
researchProduct

The use of complementary therapies for chronic pain in Italian hospices.

2013

Scopo: Sebbene ci sia un incremento dell’utilizzo delle Terapie Complemntari (CT) in Europa, ancora è poco noto l’utilizzo di esse negli hospice italiani per il trattamento del dolore cronico. Questa indagine ha lo scopo di descrivere la diffusione delle CT e le loro diverse tipologie impiegate per il trattamento del dolore cronico nel setting assistenziale delle Cure Palliative. Metodi. È stata realizzata una indagine on-line su tutto il campione dei 16 hospices presenti nel territorio della Regione Lazio, utilizzando un questionario adattato e validato per descriverne utilizzo e barriere dell’uso delle CT per il trattamento del dolore cronico oncologico e benigno. Risultati: Il tasso di r…

Complementary TherapiesHospice CareItalyhospices; chronic pain; pain management; humans; hospice care; italy; complementary therapiesPalliative careHospicesHumansPain ManagementNursingComplementary TherapyChronic PainSettore MED/45 - Scienze Infermieristiche Generali Cliniche E Pediatriche
researchProduct

Alternative and complementary therapies in osteoarthritis and cartilage repair

2020

Osteoarthritis (OA) is the most common joint condition and, with a burgeoning ageing population, is due to increase in prevalence. Beyond conventional medical and surgical interventions, there are an increasing number of ‘alternative’ therapies. These alternative therapies may have a limited evidence base and, for this reason, are often only afforded brief reference (or completely excluded) from current OA guidelines. Thus, the aim of this review was to synthesize the current evidence regarding autologous chondrocyte implantation (ACI), mesenchymal stem cell (MSC) therapy, platelet-rich plasma (PRP), vitamin D and other alternative therapies. The majority of studies were in knee OA or chond…

Complementary TherapiesMaleAgingmedicine.medical_specialtyAlternativeMEDLINEPsychological interventionOsteoarthritisReviewPlaceboMesenchymal Stem Cell TransplantationTransplantation Autologous03 medical and health sciences0302 clinical medicineChondrocytesOsteoarthritismedicineVitamin D and neurologyHumansVitamin DIntensive care medicineAutologous chondrocyte implantationddc:616030203 arthritis & rheumatology030222 orthopedicsbusiness.industryCartilageAge FactorsOsteoarthritis Cartilage Alternative Therapy Treatment HerbalVitaminsOsteoarthritis Kneemedicine.diseaseClinical trialTreatmentmedicine.anatomical_structureCartilageTreatment OutcomeHerbalFemaleTherapyGeriatrics and GerontologybusinessAging Clinical and Experimental Research
researchProduct

Complementary and alternative treatment methods in children with cancer: A population-based retrospective survey on the prevalence of use in Germany.

2008

Abstract Introduction Few studies have been conducted to date on the prevalence of use of complementary and alternative treatment methods (CAMs) in paediatric oncology, and those that have been conducted are often not representative. We therefore decided to study a representative sample of children with cancer in the German population. Patients and methods The study took the form of a retrospective survey amongst all parents whose children were first diagnosed with a disease covered by the German Childhood Cancer Registry in 2001. The primary objectives of the survey were to establish the prevalence of use of CAM and the factors related to its use. Results Of the 1595 questionnaires sent ou…

Complementary TherapiesMaleParentsCancer Researchmedicine.medical_specialtyPediatricsmedicine.medical_treatmentAlternative medicineMEDLINEDiseaseAnthroposophic medicineGermanyNeoplasmsEpidemiologymedicineHumansChildRetrospective StudiesChildhood Cancer Registrybusiness.industryInfant NewbornInfantRetrospective cohort studyHomeopathyOncologySocioeconomic FactorsFamily medicineChild PreschoolHealth Care SurveysFemalebusinessAttitude to HealthEuropean journal of cancer (Oxford, England : 1990)
researchProduct